Laboratory Corporation of America Holdings (NYSE: LH) started the day on May 25, 2023, with a price decrease of -1.07% at $213.37. During the day, the stock rose to $215.34 and sunk to $210.435 before settling in for the price of $215.67 at the close. Taking a more long-term approach, LH posted a 52-week range of $200.32-$263.12.
Unlock the Hottest Top 10 Penny Stocks Today! Discover Now
Dive into the world of lucrative penny stocks with MarketClub's groundbreaking "Smart Scan" technology! Get an instant snapshot of the top 50 high volume stocks with a clear direction and outstanding liquidity - in other words, the strongest trending. To unlock this exclusive list, simply provide your first name, last name, and email for instant access.
Gain Access to Top 10 Penny Stocks Now!.
Sponsored
The company of the Healthcare sector’s yearbook sales growth during the past 5- year span was recorded 7.60%. Meanwhile, its Annual Earning per share during the time was 15.40%. Nevertheless, stock’s Earnings Per Share (EPS) this year is -42.70%. This publicly-traded company’s shares outstanding now amounts to $88.40 million, simultaneously with a float of $88.35 million. The organization now has a market capitalization sitting at $18.84 billion. At the time of writing, stock’s 50-day Moving Average stood at $224.00, while the 200-day Moving Average is $231.55.
It is imperative to bring your focus towards the efficiency factor of the conglomerate that has a total of 80000 employees. It has generated 185,960 per worker during the last fiscal year. Meanwhile, its income per employee was 15,989. The stock had 4.96 Receivables turnover and 0.73 Total Asset turnover. For the Profitability, stocks gross margin was +27.73, operating margin was +14.31 and Pretax Margin of +10.64.
Laboratory Corporation of America Holdings (LH) Ownership Facts and Figures
Now let’s turn our focus to how large-scale investors are working with this stock of the Diagnostics & Research Industry. Laboratory Corporation of America Holdings’s current insider ownership accounts for 0.10%, in contrast to 94.40% institutional ownership. According to the most recent insider trade that took place on May 19, this organization’s CEO, Covance Drug Development sold 4,300 shares at the rate of 216.91, making the entire transaction reach 932,707 in total value, affecting insider ownership by 12,946. Preceding that transaction, on May 18, Company’s EVP, Pres Diagnostics & COO sold 1,500 for 216.77, making the whole transaction’s value amount to 325,155. This particular insider is now the holder of 6,687 in total.
Laboratory Corporation of America Holdings (LH) Earnings and Revenue Records
In the latest quarterly report released, which was put into the public domain on 3/30/2023, the organization reported $3.82 earnings per share (EPS) for the three months, lower than the consensus estimate (set at $3.96) by -$0.14. This company achieved a net margin of +8.60 while generating a return on equity of 12.56. Wall Street market experts anticipate that the next fiscal year will bring earnings of 4.37 per share during the current fiscal year.
Laboratory Corporation of America Holdings’s EPS decrease for this current 12-month fiscal period is -42.70% and is forecasted to reach 18.62 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will decrease by -6.45% through the next 5 years, which can be compared against the 15.40% growth it accomplished over the previous five years trading on the market.
Laboratory Corporation of America Holdings (NYSE: LH) Trading Performance Indicators
Let’s observe the current performance indicators for Laboratory Corporation of America Holdings (LH). It’s Quick Ratio in the last reported quarter now stands at 1.50. The Stock has managed to achieve an average true range (ATR) of 4.29. Alongside those numbers, its PE Ratio stands at $19.39, and its Beta score is 1.04. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 1.28. Similarly, its price to free cash flow for trailing twelve months is now 17.61.
In the same vein, LH’s Diluted EPS (Earnings per Share) trailing twelve months is recorded 11.00, a figure that is expected to reach 4.22 in the next quarter, and analysts are predicting that it will be 18.62 at the market close of one year from today.
Technical Analysis of Laboratory Corporation of America Holdings (LH)
If we take a close look at the recent performances of Laboratory Corporation of America Holdings (NYSE: LH), its last 5-days Average volume was 0.6 million that shows plunge from its year to date volume of 0.6 million. During the previous 9 days, stock’s Stochastic %D was recorded 33.81% While, its Average True Range was 4.30.
Raw Stochastic average of Laboratory Corporation of America Holdings (LH) in the period of the previous 100 days is set at 6.06%, which indicates a major fall in contrast to 19.34% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 14.82% that was lower than 21.64% volatility it exhibited in the past 100-days period.